Tag Archives: Chronic

FDA Approves Epclusa (sofosbuvir/velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection

Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Epclusa® (sofosbuvir 400mg/velpatasvir 100mg; sofosbuvir 200mg/velpatasvir 50 mg) for the treatment of people with chronic hepatitis C infection (HCV) as young as 6 years of age or weighing at… Read More »

FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype

FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype Print this page March 09, 2020 — The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait). It is the… Read More »

Abbott Proclaim XR 10-Year Spinal Cord Stimulator FDA Approved for Chronic Pain

September 26th, 2019 Medgadget Editors Neurology, Neurosurgery, Pain Management Abbott won approval for and is releasing a new spinal cord stimulator that can treat chronic pain for up to ten years without requiring a recharge. The Proclaim XR delivers a low dose version of Abbott’s unique BurstDR waveform, which supposedly delivers a signal similar to… Read More »

Chronic Stress Raises Your Risk of Several Types of Cardiovascular Disease

Stress has enormous implications for your health. From an evolutionary perspective, the stress response is a lifesaving biological function that enables you to instinctively square-off against an assailant, run away from a predator or take down a prey. However, those of us living in the modern world are now activating this same biological reaction in… Read More »